HomeInsightsPE

Fredun Pharmaceuticals Ltd PE Ratio

Fredun Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

8.6 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Fredun Pharmaceuticals Ltd

NSE: FREDUNPHARMA

PE

17.9

Last updated on: Nov 24, 2024

Key Highlights

  • The P/E Ratio of Fredun Pharmaceuticals Ltd is 17.9 as of 24 Nov 15:30 PM .
  • The P/E Ratio of Fredun Pharmaceuticals Ltd changed from 37.8 on March 2019 to 21.6 on March 2024 . This represents a CAGR of -8.91% over 6 years.
  • The Latest Trading Price of Fredun Pharmaceuticals Ltd is ₹ 673.7 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Fredun Pharmaceuticals Ltd

No data available

Company Fundamentals for Fredun Pharmaceuticals Ltd

No data available

Image

Fredun Pharmaceuticals Ltd

NSE: FREDUNPHARMA

Share Price

₹ 673.7

1.70 (0.25%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Fredun Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Fredun Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024673.7
21 Nov 2024672
19 Nov 2024693.45
18 Nov 2024692.85
14 Nov 2024677.95
13 Nov 2024689.85
12 Nov 2024710.05
11 Nov 2024704.45
08 Nov 2024707.8
07 Nov 2024712.9

SWOT Analysis Of Fredun Pharmaceuticals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Fredun Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Fredun Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Fredun Pharmaceuticals Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Fredun Pharmaceuticals Ltd

No data available

* All values are in %

About Fredun Pharmaceuticals Ltd

  • Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94.
  • The Company was promoted by Nariman Medhora and Daulat N Medhora.
  • The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations.
  • Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy.
  • The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products.

Fredun Pharmaceuticals Ltd News Hub

News

Fredun Pharmaceuticals AGM scheduled

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will...

Read more

2024-09-19 00:00:00

News

Fredun Pharmaceuticals to hold AGM

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will...

Read more

2024-09-19 00:00:00

News

Fredun Pharmaceuticals to hold board meeting

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 O...

Read more

2024-09-27 00:00:00

News

Fredun Pharmaceuticals to discuss results

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 ...

Read more

2024-10-16 00:00:00

News

Fredun Pharmaceuticals standalone net profit rises 8.38% in the September 2024 quarter

Net profit of Fredun Pharmaceuticals rose 8.38% to Rs 4.27 crore in the quarter ended Sept...

Read more

2024-10-28 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Fredun Pharmaceuticals Ltd

What is the current PE Ratio of Fredun Pharmaceuticals Ltd?

The Current PE Ratio of Fredun Pharmaceuticals Ltd is 17.9 as on 24 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 24 Nov 2024.

What was the PE Ratio of Fredun Pharmaceuticals Ltd last year?

The PE Ratio of Fredun Pharmaceuticals Ltd was 32.6 last year, now the PE ratio is 17.9, showing a year-on-year growth of -45.1%.

What does the PE Ratio of Fredun Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Fredun Pharmaceuticals Ltd is 17.9. This ratio indicates that investors are willing to pay 17.9 times the earnings per share for each share of Fredun Pharmaceuticals Ltd.

What is the PE Ratio Growth of Fredun Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Fredun Pharmaceuticals Ltd grew by -45.1% whereas, the EPS ratio grew by 3.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*